Results
1 -
10 of
11
(Click
here to explore results)
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 6 Discovery and Development of Ganetespib. Weiwen Ying
, 2014
, Pages 180-197
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 13 Hsp90 Inhibitors in Clinic. Emin Avsar
, 2014
, Pages 336-378
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 12 The Cancer Super-chaperone Hsp90: Drug Targeting and Post-translational Regulation. Annerleim Walton-Diaz, Sahar Khan, Jane B. Trepel, Mehdi Mollapour, Len Neckers
, 2014
, Pages 318-335
- Inhibitors of Molecular Chaperones as Therapeutic Agents, Contents
, 2014
, Pages P009-P016
- Inhibitors of Molecular Chaperones as Therapeutic Agents, Subject Index
, 2014
, Pages 414-425
- Allosterism in Drug Discovery, CHAPTER 18 Allosteric Modulators of Heat Shock Protein 90 (HSP90). Yen Chin Koay, Shelli McAlpine
, 2017
, Pages 404-426
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 1 Overview of Molecular Chaperones in Health and Disease. Tai Wang, Pablo C. EcheverrÃa, Didier Picard
, 2014
, Pages 1-36
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 4 Exploiting the Dependency of Cancer Cells on Molecular Chaperones. Swee Sharp, Jenny Howes, Paul Workman
, 2014
, Pages 126-157
- DNA Damage, DNA Repair and Disease: Volume 2, Chapter 28 The Role of PARP and the Therapeutic Potential of PARP Inhibitors in Cancer. N. J. Curtin
, 2021
, Volume 2
, Pages 319-360
- Macrocycles in Drug Discovery, CHAPTER 2 Recent Advances in Macrocyclic Hsp90 Inhibitors. D. M. Ramsey, R. R. A. Kitson, J. I. Levin, C. J. Moody, S. R. McAlpine
, 2015
, Pages 37-77